C

Citius Oncology Inc
D

CTOR

1.30000
USD
0.05
(4.00%)
مفتوح الان
حجم التداول
1,213
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
108,567,475
المقالات

العنوان: Citius Oncology Inc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in itsPhase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.